AGP Executive Report
Last update: 2 hours agoBiotech Push in Freiburg: Sartorius opened a €140m competence center in Freiburg to scale “quality-critical” materials for cell and gene therapies, including cytokines and growth factors, with GMP-ready space for up to 180 staff. Deal Closes in Oncology: Gilead has completed its $3.15bn acquisition of Germany’s Tubulis, adding next-gen antibody-drug conjugates such as TUB-040 for platinum-resistant ovarian cancer. EU Growth Warning: The European Commission cut Germany’s 2026 growth forecast to 0.6% from 1.2%, blaming tariffs, high energy prices and geopolitical uncertainty. Ukraine EU Proposal: Chancellor Merz wants “associate membership” for Ukraine—participation in EU meetings without voting rights—while keeping enlargement talks moving. Aviation Shock: Air France and Airbus were found guilty of manslaughter over the 2009 AF447 crash that killed 228 people, with both vowing to appeal. China Investment Surge: Chinese firms became Germany’s top source of foreign investment projects in 2025, overtaking the US.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
